University of Alabama at Birmingham Chief of Thoracic Surgery Robert Cerfolio, M.D., will give the 60th annual presidential address at this year’s Southern Thoracic Surgical Association meeting Nov. 2 in Scottsdale, Ariz. Cerfolio’s address is titled “How To Super Perform in Life: The Athleticism of Surgery and Beacons of Light.” It will mark his last duties as 2012-2013 president of the organization.
Cerfolio is a world-renowned thoracic surgeon who has performed more than 15,000 operations and more thoracic robotic operations than any other surgeon in the world. These include robotic pulmonary resection and esophageal surgery.
He is recognized as one of the world’s leaders in developing new clinical ways to reduce pain, reduce air leaks, and make operations and clinical pathways more efficient for patients, with less morbidity. He also has devised new ways to teach thoracic surgery.
Cerfolio has hosted more than 200 visiting surgeons from around the world to UAB to observe his novel surgical techniques and his team’s organization and efficiency. He also has been a visiting professor and given 250 lectureships and presentations at major international and national scientific meetings around the globe. Cerfolio has written more than 154 original peer-reviewed articles and more than 50 book chapters, and he is scheduled to release his first nonmedical book, “The Athleticism of Surgery,” in early 2014. In addition, he will complete his MBA degree in December.
The STSA was founded in 1954 with the purpose of disseminating knowledge and information and to encourage and stimulate progress in the fields of thoracic and cardiovascular surgery.
Today, each of the academic society’s members devotes at least 75 percent of his or her practice to these fields. A secondary objective of the STSA is to promote fellowship among the thoracic surgeons represented in the southern United States. This objective is accomplished each year through membership mailings and the Annual Meeting. Although the STSA is a regional society by definition, it represents more than 1,000 cardiothoracic surgeons throughout the United States.
Cerfolio, 51, is one of the youngest presidents of any major cardiothoracic society.
Ten-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted today 229 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 2 days ago 386 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted 6 days ago 2412 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted 7 days ago 827 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted 7 days ago 356 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted 9 days ago 710 viewsFirst-of-its-kind driving simulator lab at UAB powered by donation from Honda Manufacturing of Alabama and ALDOTThe facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.posted 14 days ago 2447 viewsUAB looking for healthy adults to participate in study on blood pressureThe UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.posted 15 days ago 701 viewsUAB observational study of Zika virus infection during pregnancy begins in BrazilUAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.posted 20 days ago 1940 viewsUAB Medical Genomics Laboratory refines its genetic testing technologyCustomized deep-coverage, next-generation sequencing will replace the current state-of-the-art approach.posted 21 days ago 1183 viewsUAB REACT aims to catalyze high-impact clinical trials in medical rehabilitationUAB’s new REACT Center is the national coordinating center for six centers designed to promote research and train scientists and clinicians in the medical rehabilitation field.posted 22 days ago 1548 viewsUAB to hold 11th annual MHRC Health Disparities SymposiumThe 11th annual UAB Health Disparities Research Symposium, April 21, will showcase compelling workshops and the groundbreaking findings of eminent researchers in the health disparities field.
UAB cleared for design stage of new Collat School of Business and Bill L. Harbert Institute for Innovation and Entrepreneurship buildingBoard approval provides authorization for stage three planning to proceed for new Bill L. Harbert Institute for Innovation and Entrepreneurship and Collat School of Business building.posted 24 days ago 3122 viewsPersonality may dictate how distracted you are while drivingUAB researchers uncover new information about drivers’ likelihood to participate in risky roadway behavior.posted 24 days ago 2122 viewsLawson receives ADA investigator awardNathaniel Lawson, DMD, assistant professor at the University of Alabama Birmingham School of Dentistry, is the recipient of the 2015 John W. Stanford New Investigator Award given by the American Dental Association.posted 24 days ago 955 viewsUAB awarded $19.5 million grant for new xenotransplantation programGift from United Therapeutics will establish Xenotransplantation Institute and bring additional resources to support the endeavor with a goal of genetically modified kidney transplants taking place by 2021.posted 27 days ago 4474 viewsAlabama Vaccine Research Clinic recruiting for new clinical trial for preventive antibody for HIVAn international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.posted 29 days ago 856 viewsCardiac arrest study showed benefit from antiarrhythmic drugsA resuscitation study found another small step to help improve out-of-hospital cardiac arrest survival.posted a while back 1570 viewsFertility Care Network provides infertility resources to families throughout stateInfertility choices for women are expanded with UAB Fertility Care Network.posted a while back 1685 viewsNew study explores patient navigator effect for those with diabetesRole of mentors for patients with diabetes is the focus of a $30,000 grant.posted a while back 1479 views
- Event Date April 21